Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Historical mysteries solved by science in 2025 - 2Lily Allen 2026 'West End Girl' Tour: How to get tickets, prices, presale info and more
- 3The 25 Most Notable Style Crossroads in History
- 4Former defense minister Gallant vacated home over security threat under Shin Bet direction
- 5Wisconsin archaeologists identify 16 ancient canoes in a prehistoric lake 'parking lot'
- 4 Jeep Models: Dominating Execution and Flexibility for Each Experience
- Monetary Wellness: Planning Tips for Independence from the rat race
- The 10 Most Noteworthy Games in History
- Remote Headphones: Improve Your Sound Insight
- 5 Great and High Evaluated Scene Configuration Administrations For 2024
- Tablets: Upgrade Your Understanding Experience
- 4 injured in suburban Philadelphia nursing home explosion file negligence lawsuit
- How to disinfect if the stomach bug hits your home
- Pick Your Number one sort of blossom
